期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 87, 期 -, 页码 25-34出版社
ELSEVIER
DOI: 10.1016/j.addr.2015.04.012
关键词
-
资金
- American Cancer Society [DHP-105, RD-324]
- American Foundation for AIDS Research [00638, 00004]
- Florida High Technology and Industry Council
- Genta, Inc.
- Heritable Disease Foundation
- Leukemia Society
- Milligen/Biosearch, Inc.
- US Army Medical Research and Development Command [W81XWH-09-1-0577, DAMD17-86-G-6037]
- US Department of Energy [ER63055]
- US National Institutes of Health [N01 CO027175, R01 CA148565, R21 DA027746, R44 CA136306, R01 CA76290, R01 CA42960, R03 TW01094, U01 CA60139, R01 GM32024, R01 GM28408, R01 GM24128, R01 GM23248]
- US National Science Foundation [BMS 75-17781, PCM 77-25211, PCM 79-23471]
Synthetic, complementary DNA single strands and short interfering RNA double strands have been found to inhibit the expression of animal, plant, and viral genes in cells, animals, and patients, in a dose dependent and sequence specific manner. DNAs and RNAs, however, are readily digested in biological systems. Hence, chemists are obliged to design and synthesize nuclease-resistant analogs of normal DNA (Fig. 1). (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
